CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 25, 2011 |
President & COO
|
President & COO | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 23,558 | -- | 50,100 |
| Feb 25, 2011 |
President & COO
|
President & COO | Form 4/A | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 9,982 | $24.53 | 40,118 |
| Mar 08, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 50,525 | $14.62 | 820,262 |
| Feb 20, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 185,100 | -- | 988,804 |
| Feb 20, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 118,017 | $14.26 | 870,787 |
| Feb 15, 2024 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 84,270 | -- | 803,704 |
| Aug 10, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 46,504 | $10.38 | 719,434 |
| Feb 21, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 85,152 | -- | 839,397 |
| Feb 21, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 73,459 | $10.50 | 765,938 |
| Feb 16, 2023 |
Director, President & CEO
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 101,911 | -- | 754,245 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.